PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro. - Wikidata - wikimedia - TriplyDB

PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro.

PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro.

http://www.wikidata.org/entity/Q42521446

about

PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer The peroxisome proliferator activated receptor delta is required for the differentiation of THP-1 monocytic cells by phorbol ester Normal and neoplastic urothelial stem cells: getting to the root of the problem Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo.PPARgamma-regulated tight junction development during human urothelial cytodifferentiation In Vitro Evaluation of Spider Silk Meshes as a Potential Biomaterial for Bladder Reconstruction.Effects of PPARgamma and combined agonists on the urinary tract of rats and other species.Chemotherapeutic drugs induce PPAR-gamma expression and show sequence-specific synergy with PPAR-gamma ligands in inhibition of non-small cell lung cancer Thiazolidinediones as anti-cancer agents.PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis.When urothelial differentiation pathways go wrong: implications for bladder cancer development and progression.Scientific Evidence and Controversies About Pioglitazone and Bladder Cancer: Which Lessons Can Be Drawn?FOXA1 and IRF-1 intermediary transcriptional regulators of PPARgamma-induced urothelial cytodifferentiation.Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypes of urothelial neoplasms Nicotine stimulates human lung cancer cell growth by inducing fibronectin expression.Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells.Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells.Neoplastic and non-neoplastic changes in F-344 rats treated with Naveglitazar, a gamma-dominant PPAR alpha/gamma agonist.Urothelial carcinogenesis in the urinary bladder of rats treated with naveglitazar, a gamma-dominant PPAR alpha/gamma agonist: lack of evidence for urolithiasis as an inciting event.Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action.

P2860

Q21328702-3CF5E2BC-E18B-4BBE-AAB7-9EFBD8611F75 Q24806798-04085675-22DB-43E4-AD62-76F4BA0B2A80 Q26825948-038DC322-392B-4B90-9737-C467281F0481 Q34548738-47B9CAD4-BD87-4FDC-9763-FBA36B88D328 Q34863027-4379D4B0-34CB-43F1-9C13-6771454B0777 Q35874141-28649E9F-527F-469E-8D32-C10C8ABCCF16 Q36210174-FC535BD6-2BB7-4EB2-8D80-3C2D69B0ED84 Q36661722-3634FAD9-31CB-4F68-9069-2433A2481FBD Q37010188-3088474F-4965-4154-BEFF-8147B639918E Q37656960-3FFDAA2B-6F0A-4EE6-A66A-05BF81F39741 Q37933675-6DFFCAC2-DD8F-4B99-8417-93C68E4904E5 Q38122640-2954250D-543B-4DD1-898A-4DAA91C9CFE7 Q38288442-0CF96AA6-03FE-4FDC-8F18-110A7FF068E4 Q38293557-116E0E74-3D23-4EBE-8116-FDD1E53232EC Q40113803-120F5A44-8A46-4D71-B66E-5E5676753E18 Q40592803-19AC98AF-2BB3-49CA-AA58-1DD75CCB28C4 Q41905030-C856887A-249B-454C-A9D6-F4E1DDB075CE Q43287595-E98A0D1D-239D-4640-A1AC-9DD39CEAC942 Q46599209-5DCFB068-C86C-41B7-B151-2935FF855894 Q53338744-8E54A1ED-5050-434D-A8BC-B83243DF5051

P2860

PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro.

http://www.wikidata.org/entity/Q42521446

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro.

@en

PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro.

@nl

type

label

PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro.

@en

PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro.

@nl

prefLabel

PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro.

@en

PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro.

@nl

P1433

Q42521446-AEAA88B0-373E-49C7-9730-82B5B045A50E

P1476

Q42521446-D0C395A1-9227-46C3-833E-376C5160682B

P2093

Q42521446-41419151-E140-44E4-82DE-5B29E95A2C9D

Q42521446-4A13A78A-3CD9-4575-BA37-77F58D2C8AE8

Q42521446-5281F340-12F0-44D6-AF3B-85A580035678

Q42521446-5CCB2ECE-1DFD-4A9E-9C7B-B989976B7370

Q42521446-5D59D39A-EDD2-42B3-A95C-A45ADA16F34B

Q42521446-8A59F829-3562-4C81-A0B6-A038ACCE6619

Q42521446-CD61F7A0-6FBD-48B4-AF78-28582950A36F

P2860

Q42521446-09249D2C-8776-4705-934E-69B7C67D6B5F

Q42521446-0DE701FA-79A4-45BD-B787-D0204A2CE3FA

Q42521446-1019D4E0-8A47-47DE-B8B7-148747DBDE1C

Q42521446-112EFC5D-A396-4424-90E3-0503C851EA90

Q42521446-147420FB-16BF-4ED7-BFA2-07AF5312A3FA

Q42521446-23A598BB-B962-471B-BB95-53655CE0D273

Q42521446-3095BF0E-2987-4EA4-B5F8-FA59B3824706

Q42521446-3DEE46EE-88AD-40BC-AE3D-BDA3B6AEF7B6

Q42521446-5036832A-BD64-45A5-B803-B1B2F02F45AE

Q42521446-553F4620-A8F6-49CE-9A69-7EDCED6A4CB4

P304

Q42521446-3D45DDE5-D33C-49BF-94A0-1ADAA5DCE064

P31

Q42521446-4269C415-1C9C-4498-A0C8-2883B4089E5C

P356

Q42521446-1254BC34-D59C-4D53-831F-BE1CCE3C8F1D

P433

Q42521446-97B9CFCE-B545-4F24-B24D-151B28AA93B3

P478

Q42521446-6A483E9E-4E7E-49FD-9E89-8EDEDA910AD3

P577

Q42521446-3CF62693-F10E-40DB-AF23-463B5AAD1DFA

P698

Q42521446-0541D157-4B2A-41D1-AD8A-E24AD98E26EA

P356

P1433

Journal of Cellular Physiology

P1476

PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro.

@en

P2093

Gaku Arai

http://www.w3.org/2001/XMLSchema#string

Guangbin Xia

http://www.w3.org/2001/XMLSchema#string

Kazunori Kihara

http://www.w3.org/2001/XMLSchema#string

Satoru Kawakami

http://www.w3.org/2001/XMLSchema#string

Tetsuo Hayashi

http://www.w3.org/2001/XMLSchema#string

Yasuhisa Fujii

http://www.w3.org/2001/XMLSchema#string

Yukio Kageyama

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of the human uroplakin 1B cDNA and analysis of its expression in urothelial-tumor cell lines and bladder-carcinoma tissue

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

Uroplakin gene expression by normal and neoplastic human urothelium

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

P304

310-319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCP.10099

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

191

http://www.w3.org/2001/XMLSchema#string

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12012326

http://www.w3.org/2001/XMLSchema#string